Table 2.
Signal | Number of Studies | PPV Range | p-value Test for Heterogeneity | Overall Estimate of PPV† (95% CI) | Overall Estimate of PPV‡ (95% CI) |
---|---|---|---|---|---|
Vitamin K given | 3 | 0.02–0.30 | <0.01 | — | — |
Activated charcoal given | 2 | 0.08–0.45 | 0.03 | — | — |
Antihistamine (e.g., diphenhydramine or hydroxyzine) given | 3 | 0.03–0.14 | <0.01 | — | — |
Oral metronidazole or vancomycin given | 2 | 0.07–0.16 | 0.06 | 0.11 (0.06–0.20) | 0.10 (0.06–0.14) |
Antidiarrheal (e.g., loperamide, diphenoxylate, bismuth) given | 3 | 0–0.11 | 0.06 | 0.09 (0.07–0.13) | 0.07 (0.00–0.15) |
Sodium polystyrene (Kayexalate®) given | 3 | 0.06–0.12 | 0.44 | 0.09 (0.06–0.13) | 0.08 (0.05–0.12) |
Oral or topical steroids (e.g., prednisone, prednisolone) given | 2 | 0.04–0.09 | <0.01 | — | — |
∗ Naloxone not included as data were available from only a single study.
† PPV calculated using GEE pooled estimate and CI.
‡ PPV calculated using fixed effects pooled estimate and CI.
PPV= positive predictive value.